{"transactions":[{"id":3965995,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":167627,"kind":"person","name":"Gormally John J","position":1,"cik":"0001661118","reported_name":"Gormally John J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-11T00:42:17.000Z","date":"2017-10-17","kind":"grant","acquired":true,"shares":150000,"price":0.88,"value":132000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan."}],"balance_after":180000,"source":{"system":"sec-edgar","filing":"0001493152-18-005018","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315218005018/form4a.xml","form_type":"4/A","original_submission_date":"2017-10-24"}},{"id":3965994,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":167627,"kind":"person","name":"Gormally John J","position":1,"cik":"0001661118","reported_name":"Gormally John J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-11T00:40:47.000Z","date":"2016-06-08","kind":"grant","acquired":true,"shares":27500,"price":1.99,"value":54725.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 8, 2016 Mr. Gormally was issued 27,500 shares of common stock (the \"Shares\") under the Company's 2013 Incentive Stock and Award Plan, as amended. Pursuant to the Restricted Stock Agreement between Mr. Gormally and the Company governing the issuance of the Shares, 9,167 of the Shares vested on June 8, 2016, 9,167 of the Shares will vest on March 1, 2017, and 9,166 of the Shares will vest on March 1, 2018."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001493152-18-005016","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315218005016/form4a.xml","form_type":"4/A","original_submission_date":"2016-06-14"}},{"id":4181112,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":167627,"kind":"person","name":"Gormally John J","position":1,"cik":"0001661118","reported_name":"Gormally John J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-10-24T20:50:40.000Z","date":"2017-10-17","kind":"gift","acquired":true,"shares":150000,"price":0.88,"value":132000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan."}],"balance_after":180000,"source":{"system":"sec-edgar","filing":"0001493152-17-011992","document":"form-4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315217011992/form-4.xml","form_type":"4"}}]}